Laban S - Search Results

1

Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers.

Huber LT, Kraus JM, Ezić J, Wanli A, Groth M, Laban S, Hoffmann TK, Wollenberg B, Kestler HA, Brunner C. Huber LT, et al. Among authors: laban s. Explor Target Antitumor Ther. 2023;4(3):422-446. doi: 10.37349/etat.2023.00143. Epub 2023 Jun 30. Explor Target Antitumor Ther. 2023. PMID: 37455825 Free PMC article.

2

[Current status of therapeutic approaches with targeted therapies in malignant thyroid cancer. Highlights from the 2011 ASCO Congress].

Uecker FC, Laban S, Knecht R. Uecker FC, et al. Among authors: laban s. HNO. 2012 May;60(5):398, 400-3. doi: 10.1007/s00106-011-2464-z. HNO. 2012. PMID: 22570003 German.

3

[New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting].

Loewenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch CJ. Loewenthal M, et al. Among authors: laban s. HNO. 2012 Nov;60(11):951-6. doi: 10.1007/s00106-012-2597-8. HNO. 2012. PMID: 23114540 German.

4

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].

Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T. Schöpper S, et al. Among authors: laban s. HNO. 2012 Nov;60(11):957-61. doi: 10.1007/s00106-012-2596-9. HNO. 2012. PMID: 23114541 German.

5

[Immunotherapy for HNSCC : Quo vadis?].

Döscher J, Busch CJ, Schuler PJ, Laban S. Döscher J, et al. Among authors: laban s. HNO. 2016 Oct;64(10):700-7. doi: 10.1007/s00106-016-0241-8. HNO. 2016. PMID: 27624904 Review. German.

6

11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma.

Clauditz TS, Gontarewicz A, Wang CJ, Münscher A, Laban S, Tsourlakis MC, Knecht R, Sauter G, Wilczak W. Clauditz TS, et al. Among authors: laban s. Diagn Mol Pathol. 2012 Sep;21(3):134-7. doi: 10.1097/PDM.0b013e318255552c. Diagn Mol Pathol. 2012. PMID: 22847156

7

[The development of TORS in Europe].

Lörincz BB, Laban S, Knecht R. Lörincz BB, et al. Among authors: laban s. HNO. 2013 Apr;61(4):294-9. doi: 10.1007/s00106-013-2678-3. HNO. 2013. PMID: 23538854 Review. German.

8

[New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress].

Laban S, Wang CJ, Knecht R, Tribius S, Münscher A. Laban S, et al. HNO. 2012 May;60(5):393-7. doi: 10.1007/s00106-011-2463-0. HNO. 2012. PMID: 22570002 German.

9

Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.

Kriegs M, Gurtner K, Can Y, Brammer I, Rieckmann T, Oertel R, Wysocki M, Dorniok F, Gal A, Grob TJ, Laban S, Kasten-Pisula U, Petersen C, Baumann M, Krause M, Dikomey E. Kriegs M, et al. Among authors: laban s. Radiother Oncol. 2015 Apr;115(1):120-7. doi: 10.1016/j.radonc.2015.02.018. Epub 2015 Mar 18. Radiother Oncol. 2015. PMID: 25796091

10

Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.

Elbaz M, Yanay N, Laban S, Rabie M, Mitrani-Rosenbaum S, Nevo Y. Elbaz M, et al. Among authors: laban s. Cell Death Dis. 2015 Mar 12;6(3):e1690. doi: 10.1038/cddis.2015.60. Cell Death Dis. 2015. PMID: 25766329 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters